FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200236876> ?p ?o ?g. }

• W4200236876 endingPage "100790" @default.
• W4200236876 startingPage "100790" @default.
• W4200236876 abstract "Hepatocellular carcinoma (HCC) represents the third cause of cancer death in men worldwide, and its increasing incidence can be explained by the increasing occurrence of non-alcoholic steatohepatitis (NASH). HCC prognosis is poor, as its 5-year overall survival is approximately 18 % and most cases are diagnosed at an inoperable advanced stage. Moreover, tumor sensitivity to conventional chemotherapeutics (particularly to cisplatin-based regimen), trans-arterial chemoembolization (cTACE), tyrosine kinase inhibitors, anti-angiogenic molecules and immune checkpoint inhibitors is limited. Oncogenic signaling pathways, such as HIF-1α and RAS/PI3K/AKT, may provoke drug resistance by enhancing the aerobic glycolysis (Warburg effect) in cancer cells. Indeed, this metabolism, which promotes cancer cell development and aggressiveness, also induces extracellular acidity. In turn, this acidity promotes the protonation of drugs, hence abrogating their internalization, since they are most often weakly basic molecules. Consequently, targeting the Warburg effect in these cancer cells (which in turn would reduce the extracellular acidification) could be an effective strategy to increase the delivery of drugs into the tumor. Phosphofructokinase-1 (PFK1) and its activator PFK2 are the main regulators of glycolysis, and they also couple the enhancement of glycolysis to the activation of key signaling cascades and cell cycle progression. Therefore, targeting this Gordian Knot in HCC cells would be of crucial importance. Here, we suggest that this could be achieved by citrate administration at high concentration, because citrate is a physiologic inhibitor of PFK1 and PFK2. As shown in various in vitro studies, including HCC cell lines, administration of high concentrations of citrate inhibits PFK1 and PFK2 (and consequently glycolysis), decreases ATP production, counteracts HIF-1α and PI3K/AKT signaling, induces apoptosis, and sensitizes cells to cisplatin treatment. Administration of high concentrations of citrate in animal models (including Ras-driven tumours) has been shown to effectively inhibit cancer growth, reverse cell dedifferentiation, and neutralize intratumor acidity, without apparent toxicity in animal studies. Citrate may also induce a rapid secretion of pro-inflammatory cytokines by macrophages, and it could favour the destruction of cancer stem cells (CSCs) sustaining tumor recurrence. Consequently, this citrate strategy could improve the tumor sensitivity to current treatments of HCC by reducing the extracellular acidity, thus enhancing the delivery of chemotherapeutic drugs into the tumor. Therefore, we propose that this strategy should be explored in clinical trials, in particular to enhance cTACE effectiveness." @default.
• W4200236876 created "2021-12-31" @default.
• W4200236876 creator A5000735715 @default.
• W4200236876 creator A5007096310 @default.
• W4200236876 creator A5029902285 @default.
• W4200236876 creator A5041420777 @default.
• W4200236876 creator A5045439081 @default.
• W4200236876 creator A5051344867 @default.
• W4200236876 creator A5062564670 @default.
• W4200236876 creator A5072677255 @default.
• W4200236876 creator A5078550481 @default.
• W4200236876 creator A5086740707 @default.
• W4200236876 creator A5089266911 @default.
• W4200236876 date "2021-12-01" @default.
• W4200236876 modified "2023-10-17" @default.
• W4200236876 title "Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?" @default.
• W4200236876 cites W1132077651 @default.
• W4200236876 cites W1641717686 @default.
• W4200236876 cites W1949652406 @default.
• W4200236876 cites W1965743177 @default.
• W4200236876 cites W1970399383 @default.
• W4200236876 cites W1971995358 @default.
• W4200236876 cites W1973137063 @default.
• W4200236876 cites W1975154077 @default.
• W4200236876 cites W1975854213 @default.
• W4200236876 cites W1981989535 @default.
• W4200236876 cites W1985458442 @default.
• W4200236876 cites W1986186950 @default.
• W4200236876 cites W1990391394 @default.
• W4200236876 cites W1993335047 @default.
• W4200236876 cites W1994303044 @default.
• W4200236876 cites W2006545650 @default.
• W4200236876 cites W2006998846 @default.
• W4200236876 cites W2008054544 @default.
• W4200236876 cites W2011255805 @default.
• W4200236876 cites W2011850094 @default.
• W4200236876 cites W2016818544 @default.
• W4200236876 cites W2018541716 @default.
• W4200236876 cites W2019953132 @default.
• W4200236876 cites W2020993937 @default.
• W4200236876 cites W2021393753 @default.
• W4200236876 cites W2022101765 @default.
• W4200236876 cites W2028593002 @default.
• W4200236876 cites W2028593825 @default.
• W4200236876 cites W2030585094 @default.
• W4200236876 cites W2033958147 @default.
• W4200236876 cites W2035534360 @default.
• W4200236876 cites W2045713322 @default.
• W4200236876 cites W2046976278 @default.
• W4200236876 cites W2050086871 @default.
• W4200236876 cites W2053069467 @default.
• W4200236876 cites W2055255976 @default.
• W4200236876 cites W2059320976 @default.
• W4200236876 cites W2060315853 @default.
• W4200236876 cites W2062484329 @default.
• W4200236876 cites W2064705056 @default.
• W4200236876 cites W2066969376 @default.
• W4200236876 cites W2068050569 @default.
• W4200236876 cites W2070669901 @default.
• W4200236876 cites W2072451938 @default.
• W4200236876 cites W2072785148 @default.
• W4200236876 cites W2074648434 @default.
• W4200236876 cites W2075162479 @default.
• W4200236876 cites W2075668803 @default.
• W4200236876 cites W2084235230 @default.
• W4200236876 cites W2084955511 @default.
• W4200236876 cites W2085386632 @default.
• W4200236876 cites W2086546138 @default.
• W4200236876 cites W2098571898 @default.
• W4200236876 cites W2100039832 @default.
• W4200236876 cites W2104921056 @default.
• W4200236876 cites W2112489161 @default.
• W4200236876 cites W2117840705 @default.
• W4200236876 cites W2121141922 @default.
• W4200236876 cites W2122012410 @default.
• W4200236876 cites W2125997578 @default.
• W4200236876 cites W2129276841 @default.
• W4200236876 cites W2129928009 @default.
• W4200236876 cites W2134730633 @default.
• W4200236876 cites W2134749067 @default.
• W4200236876 cites W2135922158 @default.
• W4200236876 cites W2136415416 @default.
• W4200236876 cites W2136749294 @default.
• W4200236876 cites W2140705832 @default.
• W4200236876 cites W2144381820 @default.
• W4200236876 cites W2144575277 @default.
• W4200236876 cites W2145757445 @default.
• W4200236876 cites W2149902856 @default.
• W4200236876 cites W2156687584 @default.
• W4200236876 cites W2162242700 @default.
• W4200236876 cites W2170677522 @default.
• W4200236876 cites W2170842763 @default.
• W4200236876 cites W2187002261 @default.
• W4200236876 cites W2212719824 @default.
• W4200236876 cites W2263171370 @default.
• W4200236876 cites W2273626774 @default.
• W4200236876 cites W2277004004 @default.
• W4200236876 cites W2291579888 @default.

• next